Pipettes in Massachusetts

Diamond Diagnostics Inc. is a specialized clinical laboratory instrumentation and consumables supplier based in Holliston, Massachusetts, founded in 1996. The company manufactures, remanufactures, and supplies new and refurbished chemistry analyzers, electrolyte analyzers, immunoassay systems, blood gas analyzers, coagulation analyzers, hematology analyzers, and molecular analyzers. With approximately 80 employees and ~$19M annual revenue, Diamond offers over 500 consumable products including reagents, quality controls, and electrodes. The company's proprietary Down-To-Frame® refurbishment process restores equipment to like-new condition. Most products hold FDA clearance and CE approval. Diamond provides comprehensive field service, depot service, preventive maintenance, remote support, control assay, and refurbishment services to clinical laboratories and hospitals globally. ISO 9001:2015 and ISO 13485:2016 certified, the company also offers OEM and contract manufacturing for third-party organizations.

Vivaproducts manufactures protein concentration, purification, and separation technologies for clinical diagnostic labs, hospital reference labs, and biopharmaceutical research organizations. The company has supplied the clinical diagnostic and biopharma marketplace for over 20 years with a comprehensive portfolio of centrifugal concentrators, dialysis systems, filtration products, and chromatography solutions. Core product lines include Vivaspin® and Vivacon® centrifugal concentrators for protein and macromolecule concentration; Vivafree™ centrifugal filters for free drug and hormone separation; BJP clinical and laboratory concentrators as economical alternatives to legacy products like Minicon®; XDB™ dialysis kits for rapid desalting and purification of antibodies, proteins, DNA/RNA, oligonucleotides, and lipid nanoparticles; and Xpress dialyzers. The company also distributes complementary biopharma research tools including Vivaflow® tangential flow filtration ultrafiltration systems, Vivapure® and Sartobind® chromatography products, Sartolab® and Sartoclear® vacuum filtration systems, and Minisart® syringe filters. Additional capabilities include NoEndo™ endotoxin removal systems and electronic/mechanical pipetting instruments. Products support applications in protein purification, sample desalting, buffer exchange, antibody processing, and nucleic acid preparation. The company emphasizes product consistency, operational efficiency, and reliable delivery to support clinical and research workflows. Customers include hospital laboratories, reference laboratories, and biotech firms conducting drug development, biologics manufacturing, and diagnostic assay development.

Nexpring Health is a global MedTech company focused on Assisted Reproductive Technology (ART), formed in 2025 through the combination of Hamilton Thorne, Cook Medical's Reproductive Health business, FUJIFILM Irvine Scientific's Medical Media Business, and several other specialized fertility providers. Headquartered in Beverly, Massachusetts, the company brings together over 40 years of cumulative industry expertise to serve embryologists, clinicians, and fertility clinics worldwide. Nexpring Health offers a comprehensive end-to-end ART portfolio encompassing innovative devices, culture media, consumables, and support services designed for every stage of the IVF cycle—from pre-IVF diagnosis and sperm preparation through ovum pickup, fertilization, embryo development, embryo transfer, and cryopreservation. Key products include the Guardia™ Access Embryo Transfer Catheter family, Gynemed Specialty Media formulations, CASA systems for semen analysis, embryo culture media, cryopreservation equipment (Kryo series), incubators, aspiration needles, micromanipulation instruments, and laboratory monitoring systems. The company emphasizes streamlined workflows, product quality, and direct collaboration with ART professionals to address challenges in fertility clinic operations and improve patient outcomes.